Literature DB >> 17459026

Utilization of health-care resources by patients with IBD in Manitoba: a profile of time since diagnosis.

Teresa Longobardi1, Charles N Bernstein.   

Abstract

OBJECTIVES: We tested the hypothesis of nonlinear longitudinal trends in health-care utilization by individuals with Crohn's disease (CD) and ulcerative colitis (UC) in Manitoba.
METHODS: Administrative databases were used to report resource use in 2000/1. A total of 5,485 cases of CD and UC and 45,279 matched controls were separated into incident cases (0-2 yr of disease), cases with longstanding disease (3-10 yr), and cases with very longstanding disease (>10 yr). Relative risk ratios (RRR) indicating the likelihood of resource use, given disease duration, were computed using multinomial logistic regression analysis. Sensitivity analysis was conducted to test the robustness of results to altering the disease duration cutoffs.
RESULTS: Independent of disease duration, in general, outpatient utilization was over twice as likely among IBD cases compared with controls whether or not the contact was made for IBD-specific reasons. The likelihood of utilization was greatest among incident cases for outpatient visits with an internist (RRR 6.16, 95% CI 5.11-7.43) and surgical visits (RRR 3.78, 95% CI 3.14-4.55). Inpatient stays for IBD-specific reasons in general were considered dependent on disease duration; in particular, there was a fourfold higher likelihood for the incident cases relative to their controls. For non-IBD-specific reasons, IBD cases were 1.5 times as likely to have inpatient stays, regardless of disease duration.
CONCLUSIONS: Our results suggest that within the first 2 yr from disease diagnosis the most costly resources were employed. We can likely measure the greatest proportion of treatment effects on resource use within a relatively short period.

Entities:  

Mesh:

Year:  2007        PMID: 17459026     DOI: 10.1111/j.1572-0241.2007.01232.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  17 in total

1.  Assessing National Trends and Disparities in Ambulatory, Emergency Department, and Inpatient Visits for Inflammatory Bowel Disease in the United States (2005-2016).

Authors:  Christopher Ma; Matthew K Smith; Leonardo Guizzetti; Remo Panaccione; Gilaad G Kaplan; Kerri L Novak; Cathy Lu; Reena Khanna; Brian G Feagan; Siddharth Singh; Vipul Jairath; Ashwin N Ananthakrishnan
Journal:  Clin Gastroenterol Hepatol       Date:  2020-01-25       Impact factor: 11.382

2.  The potential role of a self-management intervention for ulcerative colitis: a brief report from the ulcerative colitis hypnotherapy trial.

Authors:  Laurie Keefer; Jennifer L Kiebles; Monika A Kwiatek; Olafur Palsson; Tiffany H Taft; Zoran Martinovich; Terrence A Barrett
Journal:  Biol Res Nurs       Date:  2011-02-28       Impact factor: 2.522

Review 3.  Biomarkers in inflammatory bowel disease: current practices and recent advances.

Authors:  Heba N Iskandar; Matthew A Ciorba
Journal:  Transl Res       Date:  2012-02-01       Impact factor: 7.012

Review 4.  Inflammatory bowel disease: a Canadian burden of illness review.

Authors:  Angela Rocchi; Eric I Benchimol; Charles N Bernstein; Alain Bitton; Brian Feagan; Remo Panaccione; Kevin W Glasgow; Aida Fernandes; Subrata Ghosh
Journal:  Can J Gastroenterol       Date:  2012-11       Impact factor: 3.522

5.  Trends in the surgical treatment of ulcerative colitis over time: increased mortality and centralization of care.

Authors:  Michelle C Ellis; Brian S Diggs; John T Vetto; Daniel O Herzig
Journal:  World J Surg       Date:  2011-03       Impact factor: 3.352

6.  Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease.

Authors:  Michael D Kappelman; Carol Q Porter; Joseph A Galanko; Sheryl L Rifas-Shiman; Daniel A Ollendorf; Robert S Sandler; Jonathan A Finkelstein
Journal:  Inflamm Bowel Dis       Date:  2011-01       Impact factor: 5.325

7.  Behavioral interventions may prolong remission in patients with inflammatory bowel disease.

Authors:  Laurie Keefer; Jennifer L Kiebles; Zoran Martinovich; Elyse Cohen; Alyssa Van Denburg; Terrence A Barrett
Journal:  Behav Res Ther       Date:  2010-12-30

8.  Diagnostic ionizing radiation exposure in a population-based sample of children with inflammatory bowel diseases.

Authors:  Lena Palmer; Hans Herfarth; Carol Q Porter; Lynn A Fordham; Robert S Sandler; Michael D Kappelman
Journal:  Am J Gastroenterol       Date:  2009-08-18       Impact factor: 10.864

9.  Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014.

Authors:  S Ballou; W Hirsch; P Singh; V Rangan; J Nee; J Iturrino; T Sommers; J Zubiago; N Sengupta; A Bollom; M Jones; A C Moss; S N Flier; A S Cheifetz; A Lembo
Journal:  Aliment Pharmacol Ther       Date:  2018-02-07       Impact factor: 8.171

10.  Evaluation of the patient-reported outcomes measurement information system in a large cohort of patients with inflammatory bowel diseases.

Authors:  Michael D Kappelman; Millie D Long; Christopher Martin; Darren A DeWalt; Patricia M Kinneer; Wenli Chen; James D Lewis; Robert S Sandler
Journal:  Clin Gastroenterol Hepatol       Date:  2013-10-29       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.